Long-Acting β-agonist/Inhaled Corticosteroid Therapy and Asthma Mortality Pharmacoepidemiological Study of Long-Acting β-agonist or Inhaled Corticosteroid Therapy and Asthma Mortality: Clinical…

QUT mathematician, physician and Australian Research Council Future Fellow, Associate Professor Dan Nicolau, is a lead researcher in the STOIC…

Add-on tiotropium versus step-up inhaled corticosteroid plus long-acting beta-2‐agonist in real-world patients with asthma Allergy and Asthma Proceedings, 2020 A…

As the COVID19 pandemic spreads across the world, its primary manifestation in severe or critical disease remains respiratory, beginning with…

Researchers from Queensland University of Technology and Oxford University are working in collaboration to begin human clinical trials of inhaled…

Corticosteroid drugs that are given by inhalers to children with asthma may suppress their growth, evidence suggests. Two new systematic…

Asthma does not appear to increase the risk of COVID­19 Older age and conditions such as heart disease, high blood…

Asthma is a chronic inflammatory disease characterized by recurrent respiratory symptoms such as breathlessness, cough, and wheezing as well as…

Budesonide/salmeterol in fixed-dose combination for the treatment of asthma Fixed-dose combinations (FDC) of inhaled corticosteroid (ICS) and long-acting beta-agonist (LABA)…

Treatment comparison of budesonide/formoterol with salmeterol/fluticasone propionate in adults aged > or =16 years with asthma: post hoc analysis of…

Combining tiotropium and salmeterol in COPD: Effects on airflow obstruction and symptoms Affiliations Clinical information on 24-h spirometric efficacy of…